Global pharmaceutical packaging firm Origin has announced it is opening a second UK facility at a thriving science campus.
The business, which is headquartered in Melton, East Yorkshire, has invested heavily in its current base in the last two years.
It now hopes the new facility at Alderley Park in Macclesfield will provide a perfect home to specialise in its cutting-edge pharmaceutical packaging products.
Rich Quelch, global head of marketing at Origin, said: “Alderley Park was the natural choice for Origin to open its next strategic UK office, helping us to create strong partnerships on the ground with emerging UK pharma start-ups, in addition to our ever-expanding global network of clients.
It’s a fantastic opportunity to support the next generation of UK pharma companies and create accessibility for them to drop in and engage with our packaging technologists.”
Origin designs, manufactures and delivers innovative healthcare packaging for the pharmaceutical industry.
It works with global pharmaceutical firms to help reduce costs and increase speed to market for products.
At the new Alderley Park facility, Origin will introduce pharma start-ups to the latest digital products, including Smart-I, one of the world’s most advanced anti-counterfeiting solutions using encryption technology to prevent the duplication of data and heighten security.
The growing community of biotech and life science SMEs at the park will have on-site access to Origin’s packaging technologists, who specialise in digital secondary packaging, compliant primary packaging and child-resistant design.
The announcement also coincides with Origin welcoming Graham Howieson as a new board member.
Graham is a well-known and respected figure in the life science market, with his expertise spanning all aspects of packaging design through to product commercialisation.
Graham Howieson, head of innovation & digital at Origin, said: “I am extremely pleased to be joining the board of Origin, a company with an outstanding industry-wide reputation for delivering the next generation of packaging solutions.
Origin is now poised for its next stage of growth, propelled by new innovative smart packaging techniques utilising data encryption software and the opening of its brand-new facility at Alderley Park, the largest and best invested life science R&D facilities in the UK.”
Origin’s team and capacity will continue to grow at Alderley Park over the coming 24 to 36 months, in line with the needs of surrounding partners.
Origin’s long-term aim is to become the packaging innovation office for the site, promoting innovative thinking in the community and supporting the next generation of UK pharma talent.
The recently developed CliniWatch™, purposely designed for clinical trials, is also a core offering in Origin’s digital portfolio allowing secure, two-way communication between the patient and the associated packaging or medical device.
